AegirBio AB Ordinary Shares AEGIR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- SEK 0.52
- Day Range
- SEK 0.48–0.52
- 52-Week Range
- SEK 0.48–2.10
- Bid/Ask
- SEK 0.49 / SEK 0.50
- Market Cap
- SEK 15.21 Mil
- Volume/Avg
- 98,360 / 141,066
Key Statistics
- Price/Earnings (Normalized)
- 0.05
- Price/Sales
- 140.11
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
AegirBio AB is a Swedish diagnostic company, specializes in developing a home testing platform for oral health, therapeutic drug monitoring and infectious diseases. The current product line up includes the Veritope technology, featuring intact natalizumab in MS, along with the MagniaReader designed for both research and veterinary applications.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 15
- Website
- https://www.aegirbio.com
Valuation
|
Metric
|
AEGIR
|
|---|---|
Price/Earnings (Normalized) | 0.05 |
Price/Book Value | 1.87 |
Price/Sales | 140.11 |
Price/Cash Flow | — |
Price/Earnings
AEGIR
Financial Strength
|
Metric
|
AEGIR
|
|---|---|
Quick Ratio | 2.53 |
Current Ratio | 2.53 |
Interest Coverage | −35.53 |
Quick Ratio
AEGIR
Profitability
|
Metric
|
AEGIR
|
|---|---|
Return on Assets (Normalized) | −61.72% |
Return on Equity (Normalized) | −86.45% |
Return on Invested Capital (Normalized) | −71.71% |
Return on Assets
AEGIR
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Gvwpncwx | Pvxjhx | $185.4 Bil | |
SYK
| Stryker Corp | Lxchmmgpj | Jtr | $127.7 Bil | |
BSX
| Boston Scientific Corp | Vtxsbtgds | Tngrgj | $107.6 Bil | |
MDT
| Medtronic PLC | Wvhvzwhz | Kqmlrsd | $105.9 Bil | |
DXCM
| DexCom Inc | Swwzgnwzr | Nybf | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Dvmqlmql | Twrvm | $52.0 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Ybchycmgpd | Wrssh | $24.6 Bil | |
ALGN
| Align Technology Inc | Gryxpgwwy | Jdlbpz | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Dgymbbmm | Txnnntd | $18.7 Bil | |
PODD
| Insulet Corp | Hbbycdswg | Fhqzxk | $11.6 Bil |